Roivant Sciences Ltd. – Investors and Politicians Who Own It
ROIV, 2 share classes and securities
Investors who own it
10 tracked investors, $1.8B in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Farallon Capital ManagementQ2 2026 | $506.4M | 2.34% |
Joseph EdelmanPerceptive Advisors, Q2 2026 | $286.1M | 4.30% |
Darwin Global ManagementQ2 2026 | $234.3M | 6.23% |
Andreas HalvorsenViking Global Investors, Q2 2026 | $221.9M | 0.63% |
David RosenRubric Capital Management, Q2 2026 | $212.3M | 1.95% |
Julian i Felix BakerBaker Bros. Advisors, Q2 2026 | $166.9M | 0.84% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $111.7M | 5.11% |
Lee AinslieMaverick Capital, Q2 2026 | $100.1M | 0.88% |
Anand ParekhAlyeska Investment Group, Q2 2026 | $5.2M | 0.01% |
Polen CapitalQ2 2026 | $306.4K | 0.00% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Farallon Capital Management | Added +48% | 14,309,000 |
| David Rosen | Added +20% | 6,000,000 |
| Joseph Edelman | Reduced −2.4% | 8,085,461 |
| Lee Ainslie | Added +74% | 2,829,024 |
| Darwin Global Management | Reduced −0.7% | 6,747,300 |
| Andreas Halvorsen | Reduced −5.7% | 6,271,467 |
| Julian i Felix Baker | Reduced −3.1% | 4,716,831 |
| Daniel Schneeberger | Reduced −3.9% | 3,157,008 |
| Anand Parekh | New | 148,115 |
| Polen Capital | New | 8,659 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
| Politician | Action | Traded |
|---|---|---|
Lisa C. McClainSpouseR-MI · House | Sold$1K–$15K | Oct 31, 2025disclosed Nov 21, 2025 |
Lisa C. McClainSpouseR-MI · House | Sold$1K–$15K | Oct 30, 2025disclosed Nov 21, 2025 |
Lisa C. McClainSpouseR-MI · House | Bought$1K–$15K | Oct 30, 2025disclosed Nov 21, 2025 |
Lisa C. McClainSpouseR-MI · House | Bought$1K–$15K | Jun 17, 2025disclosed Aug 13, 2025 |